About Northeast Georgia Heart Center, Gainesville, Georgia, USANortheast Georgia Heart Center (NGHS) is the state's leader in cardiac care. The physicians at The Heart Center are consistently recognized as some of the top cardiovascular physicians in the country. It is through their leadership and collaboration that Northeast Georgia Medical Center has been recognized as the #1 heart hospital in the State of Georgia for the last seven years running, according to HealthGrades © nationally recognized organization to rank healthcare facilities based on outcomes for a variety of diagnoses and procedures. Our cardiologists have the experience that leads to expertise. We perform more than 5,000 cardiac procedures and consult more than 30,000 patients each year. Patients and families can trust the unsurpassed experience the physicians at The Heart Center provide. Our physicians remain on the forefront of prevention and disease management by our participation in clinical research and trials. We contribute at a global level to the advancement of cardiovascular treatments. For more information on NGHS please go to: www.nghs.com

About Kips Bay MedicalKips Bay Medical, Inc., founded in 2007 and headquartered in Minneapolis, Minnesota, is a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, or eSVS MESH, for use in coronary artery bypass grafting surgery. The eSVS MESH is a nitinol mesh sleeve that, when placed on the outside of a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and long-term performance of the saphenous vein graft. Additional information about Kips Bay Medical, Inc. can be found at www.KipsBayMedical.com.

Safe HarborCertain statements in this news release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are provided under the protection of the safe harbor for forward-looking statements provided by that Act. Statements in this release regarding the eSVS Mesh as a tool to improve clinical outcomes and the use of the data from this study as the basis for filing a request for an investigational device exemption to perform a pivotal trial in the U.S. are examples of forward-looking statements. These forward-looking statements involve risks and uncertainties which could cause results to differ materially from those projected, including but not limited to the risks detailed from time to time in Kips Bay Medical’s SEC reports, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. Kips Bay Medical encourages you to consider all of these risks, uncertainties and other factors carefully in evaluating the forward-looking statements contained in this release.

If you liked this article you might like

3 Stocks Moving The Health Services Industry Upward

3 Stocks Under $10 Making Big Moves

4 Health Care Stocks Under $10 to Watch

5 Worst IPOs of 2011

IPO Lessons From Pandora